Soligenix Story

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:4em;'>SO</div>
SNGX -- USA Stock  

USD 1.84  0.10  5.15%

Whilst many millenniums are getting more into healthcare space, it makes sense to break down Soligenix against current trends within the economy. As we have suggested previously, Soligenix is beginning its slide as investors shift to be more bearish due to the increased sector volatility. The returns on investing in Soligenix and the market returns of the last few months appear uncorrelated. Weak technical and fundamental indicators of the company may also suggest signs of long term losses for Soligenix investors. Soligenix is scheduled to announce its earnings tomorrow.
Published over a month ago
View all stories for Soligenix | View All Stories
Should you buy Soligenix (NASDAQ:SNGX) based on current technical indicators?
This firm's average rating is Strong Buy from 2 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Soligenix market sentiment investors' perception of the future value of Soligenix. Let us look at a few aspects of Soligenix technical analysis. The company recorded a loss per share of 0.74. Soligenix had not issued any dividends in recent years. The entity had 1:10 split on the 7th of October 2016.
Using predictive technical analysis, we will analyze different prices and returns patterns and diagnose historical swings to determine the real value of Soligenix. In general, we focus on analyzing Soligenix stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Soligenix's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Soligenix's intrinsic value. In addition to deriving basic predictive indicators for Soligenix, we also check how macroeconomic factors affect Soligenix price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.

How does Soligenix Stands against Peers?

Analyzing Soligenix competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to Soligenix across multiple sectors and thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be.
Check out Soligenix Competition Details

How Soligenix utilizes its cash?

To perform a cash flow analysis of Soligenix, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Soligenix is receiving and how much cash it distributes out in a given period. The Soligenix cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.

Acquisition by Diane Parks of 15228 shares of Soligenix subject to Rule 16b-3

Legal trades by Soligenix insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Soligenix insider trading alert for grant of stock option (right to buy) by Diane Parks, the corporate stakeholder, on 18th of September 2020. This event was filed by Soligenix Inc with SEC on 2020-09-18. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Closer look at Soligenix Semi Variance

Soligenix has current Semi Variance of 19.05. Semi-variance provides a good measure of downside volatility for equity or a portfolio. It is similar to variance, but it only looks at periods where the returns are less than the target or average level.

Semi-variance is the square of semi-deviation. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.

Semi Variance 
SUM = Summation notation
RET DEV = Actual return deviation over selected period
N(ZERO) = Number of points with returns less than zero
Let's now compare Soligenix Semi Variance to its closest peers:

Is Soligenix showing appearance of lower volatility?

The jensen alpha is down to 0.5 as of today. Soligenix is displaying above-average volatility over the selected time horizon. Investors should scrutinize Soligenix independently to ensure intended market timing strategies are aligned with expectations about Soligenix volatility.

The Bottom Line

While many of the other players in the biotechnology industry are either recovering or due for a correction, Soligenix may not be as strong as the others in terms of longer-term growth potentials. The inconsistency in the assessment between current Soligenix valuation and our trade advice on Soligenix is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Soligenix.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of Soligenix. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to